Geron GERN Royalties — Total revenues

Other product segments

Similar metrics at other companies

NVAXRoyalties — Total Revenue

$3.52M—

LGNDRoyalties — Total revenues and income

$42.96M+56.3%

SUPNRoyalty, licensing, and other revenues — Total revenues

$29.31M+274%

HRBRoyalties — Total revenues

$128.18M-4.3%

ABCLLicensing and royalty revenue — Total Revenue

$191K+14.4%

KTBRoyalty — Net revenues

$14.43M+26.0%

Questions, answered.

What is Geron's royalties — total revenues?

Geron (GERN) reported royalties — total revenues of $66K in Q1 2026.

How has Geron's royalties — total revenues changed year-over-year?

Geron's royalties — total revenues decreased by 60.5% year-over-year, from $167K to $66K.

What is the long-term trend for Geron's royalties — total revenues?

Over 2 years (2023 to 2025), Geron's royalties — total revenues has grown at a 4.3% compound annual growth rate (CAGR), from $237K to $258K.

What does royalties — total revenues mean?

This metric represents the total gross income generated from licensing intellectual property or drug rights to third-party partners. It reflects the commercial success and market adoption of the company's proprietary technology as measured by royalty payments received under collaboration or licensing agreements. This revenue stream serves as a key indicator of the company's ability to monetize its research and development pipeline without direct commercialization costs.